<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two patients who developed <z:e sem="disease" ids="C0020640" disease_type="Disease or Syndrome" abbrv="">hypoprothrombinemia</z:e> and <z:mp ids='MP_0001914'>bleeding</z:mp> due to <z:chebi fb="0" ids="40303">lovastatin</z:chebi>-<z:chebi fb="8" ids="10033">warfarin</z:chebi> drug interaction are described </plain></SENT>
<SENT sid="1" pm="."><plain>Because of the wider use of <z:chebi fb="0" ids="40303">lovastatin</z:chebi> and <z:chebi fb="8" ids="10033">warfarin</z:chebi>, heightened clinical awareness of this potentially serious interaction must be publicized </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, prothrombin time should be monitored diligently when <z:chebi fb="8" ids="10033">warfarin</z:chebi> is prescribed to patients receiving <z:chebi fb="0" ids="40303">lovastatin</z:chebi> </plain></SENT>
</text></document>